Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	Znf_CHHC	HNRNPF HNRNPH1 HNRNPH2	1.34e-06	3	207	3	IPR012996
Domain	CAC1F_C	CACNA1C CACNA1D CACNA1F	1.34e-06	3	207	3	IPR031688
Domain	zf-RNPHF	HNRNPF HNRNPH1 HNRNPH2	1.34e-06	3	207	3	PF08080
Domain	CAC1F_C	CACNA1C CACNA1D CACNA1F	1.34e-06	3	207	3	PF16885
Domain	VDCC_L_a1su	CACNA1C CACNA1D CACNA1F	5.32e-06	4	207	3	IPR005446
Domain	Ca_chan_IQ	CACNA1C CACNA1D CACNA1F	4.54e-05	7	207	3	SM01062
Domain	Ca_chan_IQ	CACNA1C CACNA1D CACNA1F	4.54e-05	7	207	3	PF08763
Domain	VDCC_a1su_IQ	CACNA1C CACNA1D CACNA1F	4.54e-05	7	207	3	IPR014873
Domain	GPHH	CACNA1C CACNA1D CACNA1F	4.54e-05	7	207	3	PF16905
Domain	GPHH_dom	CACNA1C CACNA1D CACNA1F	4.54e-05	7	207	3	IPR031649
Domain	TSP_1	CILP2 SEMA5B ADAMTSL4 ADAMTS2 THSD7B HMCN1	6.92e-05	63	207	6	PF00090
Domain	TSP1	CILP2 SEMA5B ADAMTSL4 ADAMTS2 THSD7B HMCN1	8.26e-05	65	207	6	SM00209
Domain	TSP1_rpt	CILP2 SEMA5B ADAMTSL4 ADAMTS2 THSD7B HMCN1	8.26e-05	65	207	6	IPR000884
Domain	TSP1	CILP2 SEMA5B ADAMTSL4 ADAMTS2 THSD7B HMCN1	8.26e-05	65	207	6	PS50092
Domain	VDCCAlpha1	CACNA1C CACNA1D CACNA1F	1.52e-04	10	207	3	IPR002077
Pathway	KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY	CACNA1C CACNA1D CACNA1F	2.55e-05	6	155	3	M47762
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	VWA8 KEAP1 ATG2A ZFYVE1 HEPH NRXN3 NRXN2 SEMA5B HPS4 FLYWCH1 ZNF212 TRIOBP SMPD4 CHD8 KIAA1614 URGCP CELSR3 CHD5 DHX34	1.01e-09	529	215	19	14621295
Pubmed	Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes.	TPO ZNF423 ABCA7 B3GNT6 C4B URGCP ELANE GPR156	5.45e-08	84	215	8	15203218
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ANKS6 VWA8 ATG2A FHIP1B ARHGEF11 NPHP4 ZDHHC8 ABCA7 PPP1R26 ZGPAT PHLDB1 SLC38A10 STX4 KCNH2 HERC1 ESYT1 CHD8 PIP5K1C CELSR3 CHD5 HELZ2 PC DHX34 AHNAK2	1.10e-07	1105	215	24	35748872
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	VWA8 ARHGEF11 PPP1R26 NRXN2 SORBS2 ZNFX1 THSD7B SPTBN4 CELSR3	1.29e-07	130	215	9	12421765
Pubmed	Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues.	HNRNPF HNRNPH1 HNRNPH2	2.33e-07	3	215	3	14980514
Pubmed	Heterogeneous nuclear ribonucleoproteins H, H', and F are members of a ubiquitously expressed subfamily of related but distinct proteins encoded by genes mapping to different chromosomes.	HNRNPF HNRNPH1 HNRNPH2	2.33e-07	3	215	3	7499401
Pubmed	hnRNPs H, H' and F behave differently with respect to posttranslational cleavage and subcellular localization.	HNRNPF HNRNPH1 HNRNPH2	2.33e-07	3	215	3	10456323
Pubmed	Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance.	HNRNPH1 HNRNPH2 TYMP	2.33e-07	3	215	3	21068389
Pubmed	Beta-adrenergic-regulated phosphorylation of the skeletal muscle Ca(V)1.1 channel in the fight-or-flight response.	CACNA1C CACNA1D CACNA1F	9.28e-07	4	215	3	20937870
Pubmed	Complement C4A Regulates Autoreactive B Cells in Murine Lupus.	AICDA C4A C4B	2.31e-06	5	215	3	33147456
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	ZNF423 HNRNPH2 HOXA1 PHLDB1 ADAMTSL4 ANKRD35 CACNA1C SORBS2 TNIP2 ZNF212 TRIOBP KLC4 KIF7 SPTBN4 SNAPC2	2.48e-06	560	215	15	21653829
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	VWA8 DIS3L HLCS KEAP1 SOWAHC ZC3H3 ABCA7 TRIP4 ACAD11 HAX1 TAF7 ZNF212 AOX1 OBSL1 CHD8 KIF7 SART1 ARSB CHD5 ZBTB10 DHX34	6.73e-06	1116	215	21	31753913
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	CILP2 SEMA5B ADAMTSL4 ADAMTS2 THSD7B HMCN1	7.35e-06	75	215	6	20637190
Pubmed	Enhanced expression of L-type Cav1.3 calcium channels in murine embryonic hearts from Cav1.2-deficient mice.	CACNA1C CACNA1D CACNA1F	8.01e-06	7	215	3	12900400
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	IQSEC2 ZMYM2 KEAP1 ARHGEF11 CCDC177 EFTUD2 SORBS2 MINK1 TRIOBP CHD8 ZNFX1 TBL1XR1 ATF6B ADAM22 KIF7 SPTBN4 SART1 DCHS1 NEURL4	9.78e-06	963	215	19	28671696
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	ZNF423 ZMYM2 HNRNPF HNRNPH1 HNRNPH2 EFTUD2 ACAD11 CHD8 CPS1 TBL1XR1 PHC1 KIF7	1.09e-05	411	215	12	35182466
Pubmed	Impaired antibody response causes persistence of prototypic T cell-contained virus.	AICDA C4A C4B	1.28e-05	8	215	3	19355789
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	VWA8 ACO2 ZNF423 ZMYM2 HNRNPF HNRNPH1 HNRNPH2 EFTUD2 NRXN2 HAX1 SORBS2 MYO18A TRIOBP SMPD4 AARSD1 PCF11 SART1 LLGL1 HELZ2 CPSF3	1.46e-05	1082	215	20	38697112
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ERBB3 HNRNPF ACAD11 C4A C4B USP13 SCAF8 MINK1 OBSL1 CHD8 ZNFX1 URGCP LLGL1 ZBTB11 DHX34	1.46e-05	650	215	15	38777146
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ERBB3 DIS3L ZNF423 IQSEC2 HLCS ZMYM2 DARS1 HNRNPF CEP350 HPS4 USP13 SORBS2 OBSL1 TRIOBP ZBTB47 ZNFX1 ADAM22 SPTBN4 CELSR3 PC ZBTB11 JPH3	1.75e-05	1285	215	22	35914814
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	DIS3L HLCS ATG2A FHIP1B ARHGEF11 ACE HNRNPH1 HNRNPH2 CEP350 NSFL1C ZNF598 VBP1 ESYT1 KLC4 KIF7 PC NEURL4	2.57e-05	853	215	17	28718761
Pubmed	Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.	HNRNPF HNRNPH1 HNRNPH2	3.71e-05	11	215	3	21900255
Pubmed	NCAM induces CaMKIIalpha-mediated RPTPalpha phosphorylation to enhance its catalytic activity and neurite outgrowth.	CACNA1C CACNA1D CACNA1F	3.71e-05	11	215	3	18809727
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	3.80e-05	2	215	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	3.80e-05	2	215	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	3.80e-05	2	215	2	15998580
Pubmed	Synaptic modulators Nrxn1 and Nrxn3 are disregulated in a Disc1 mouse model of schizophrenia.	DISC1 NRXN3	3.80e-05	2	215	2	21321563
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	3.80e-05	2	215	2	19062096
Pubmed	Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events.	KCNH2 CACNA1C	3.80e-05	2	215	2	33002116
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	3.80e-05	2	215	2	19933335
Pubmed	The hnRNP F protein: unique primary structure, nucleic acid-binding properties, and subcellular localization.	HNRNPF HNRNPH1	3.80e-05	2	215	2	7512260
Pubmed	Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.	C4A C4B	3.80e-05	2	215	2	2459207
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	3.80e-05	2	215	2	17645767
Pubmed	The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells.	HNRNPF HNRNPH2	3.80e-05	2	215	2	37399401
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	3.80e-05	2	215	2	12207352
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	3.80e-05	2	215	2	27758680
Pubmed	Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.	C4A C4B	3.80e-05	2	215	2	22387014
Pubmed	Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.	C4A C4B	3.80e-05	2	215	2	23749435
Pubmed	Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.	C4A C4B	3.80e-05	2	215	2	23918728
Pubmed	Different roles attributed to Cav1 channel subtypes in spontaneous action potential firing and fine tuning of exocytosis in mouse chromaffin cells.	CACNA1C CACNA1D	3.80e-05	2	215	2	21054386
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	3.80e-05	2	215	2	3037333
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	3.80e-05	2	215	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	3.80e-05	2	215	2	4216347
Pubmed	Sequence determination of the thiolester site of the fourth component of human complement.	C4A C4B	3.80e-05	2	215	2	6950384
Pubmed	Elevated Thyroid Autoantibodies Aggravate Stroke Severity in Euthyroidism with Acute Ischemic Stroke.	TPO TG	3.80e-05	2	215	2	35256895
Pubmed	Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.	C4A C4B	3.80e-05	2	215	2	8660986
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	3.80e-05	2	215	2	8428773
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	3.80e-05	2	215	2	24638111
Pubmed	The small RNA mascRNA differentially regulates TLR-induced proinflammatory and antiviral responses.	HNRNPF HNRNPH1	3.80e-05	2	215	2	34582376
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	3.80e-05	2	215	2	21345967
Pubmed	Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing.	CACNA1D CACNA1F	3.80e-05	2	215	2	25966695
Pubmed	Post-transcriptional regulation of mu-opioid receptor: role of the RNA-binding proteins heterogeneous nuclear ribonucleoprotein H1 and F.	HNRNPF HNRNPH1	3.80e-05	2	215	2	21739230
Pubmed	Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.	C4A C4B	3.80e-05	2	215	2	2572548
Pubmed	The complement component C4 of mammals.	C4A C4B	3.80e-05	2	215	2	2302180
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	3.80e-05	2	215	2	22151770
Pubmed	C4d-positive chronic rejection: a frequent entity with a poor outcome.	C4A C4B	3.80e-05	2	215	2	18091514
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	3.80e-05	2	215	2	29080553
Pubmed	An improved targeted cAMP sensor to study the regulation of adenylyl cyclase 8 by Ca2+ entry through voltage-gated channels.	CACNA1C CACNA1D	3.80e-05	2	215	2	24086669
Pubmed	Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.	C4A C4B	3.80e-05	2	215	2	6589636
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	3.80e-05	2	215	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	3.80e-05	2	215	2	17728371
Pubmed	Structure and organization of the C4 genes.	C4A C4B	3.80e-05	2	215	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	3.80e-05	2	215	2	6149581
Pubmed	Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.	CACNA1C CACNA1D	3.80e-05	2	215	2	26049024
Pubmed	The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.	C4A C4B	3.80e-05	2	215	2	12115608
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	3.80e-05	2	215	2	3542363
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	3.80e-05	2	215	2	2387317
Pubmed	Analysis of KCNH2 and CACNA1C schizophrenia risk genes on EEG functional network modulation during an auditory odd-ball task.	KCNH2 CACNA1C	3.80e-05	2	215	2	30607529
Pubmed	Genetic polymorphisms of L-type calcium channel alpha1C and alpha1D subunit genes are associated with sensitivity to the antihypertensive effects of L-type dihydropyridine calcium-channel blockers.	CACNA1C CACNA1D	3.80e-05	2	215	2	19225208
Pubmed	Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.	C4A C4B	3.80e-05	2	215	2	16908004
Pubmed	Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB.	CACNA1C CACNA1D	3.80e-05	2	215	2	16706838
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	3.80e-05	2	215	2	7365238
Pubmed	Temperature-sensitive Cav1.2 calcium channels support intrinsic firing of pyramidal neurons and provide a target for the treatment of febrile seizures.	CACNA1C CACNA1D	3.80e-05	2	215	2	23761887
Pubmed	Association of CILP2 and ACE gene polymorphisms with cardiovascular risk factors in Slovak midlife women.	ACE CILP2	3.80e-05	2	215	2	24350279
Pubmed	Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.	C4A C4B	3.80e-05	2	215	2	7391573
Pubmed	Non-voltage-gated L-type Ca2+ channels in human T cells: pharmacology and molecular characterization of the major alpha pore-forming and auxiliary beta-subunits.	CACNA1C CACNA1D	3.80e-05	2	215	2	14981074
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	3.80e-05	2	215	2	17971360
Pubmed	CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum.	CACNA1C CACNA1D	3.80e-05	2	215	2	25292336
Pubmed	Clinical features of patients with homozygous complement C4A or C4B deficiency.	C4A C4B	3.80e-05	2	215	2	29928053
Pubmed	Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.	C4A C4B	3.80e-05	2	215	2	17971229
Pubmed	Mutations in the genes for thyroglobulin and thyroid peroxidase cause thyroid dyshormonogenesis and autosomal-recessive intellectual disability.	TPO TG	3.80e-05	2	215	2	27305979
Pubmed	Ca(v)1.3 channels produce persistent calcium sparklets, but Ca(v)1.2 channels are responsible for sparklets in mouse arterial smooth muscle.	CACNA1C CACNA1D	3.80e-05	2	215	2	17526649
Pubmed	Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.	TPO TG	3.80e-05	2	215	2	10487692
Pubmed	Ligand-activated signal transduction in the 2-cell embryo.	CACNA1C CACNA1D	3.80e-05	2	215	2	12606379
Pubmed	Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.	C4A C4B	3.80e-05	2	215	2	6881182
Pubmed	Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators.	CACNA1C CACNA1D	3.80e-05	2	215	2	24941892
Pubmed	Mammalian homolog of Drosophila tumor suppressor lethal (2) giant larvae interacts with basolateral exocytic machinery in Madin-Darby canine kidney cells.	STX4 LLGL1	3.80e-05	2	215	2	11809830
Pubmed	Partial C4 deficiency in juvenile idiopathic arthritis patients.	C4A C4B	3.80e-05	2	215	2	17921792
Pubmed	Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.	C4A C4B	3.80e-05	2	215	2	21880985
Pubmed	Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.	C4A C4B	3.80e-05	2	215	2	6978711
Pubmed	Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.	C4A C4B	3.80e-05	2	215	2	35898513
Pubmed	Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.	C4A C4B	3.80e-05	2	215	2	28873507
Pubmed	Equal sensitivity of Cav1.2 and Cav1.3 channels to the opposing modulations of PKA and PKG in mouse chromaffin cells.	CACNA1C CACNA1D	3.80e-05	2	215	2	22826131
Pubmed	C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels.	CACNA1D CACNA1F	3.80e-05	2	215	2	16921373
Pubmed	Transcriptional regulation of L-type calcium channel subtypes Cav1.2 and Cav1.3 by nicotine and their potential role in nicotine sensitization.	CACNA1C CACNA1D	3.80e-05	2	215	2	24470632
Pubmed	Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.	C4A C4B	3.80e-05	2	215	2	276882
Pubmed	Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.	C4A C4B	3.80e-05	2	215	2	6832377
Pubmed	Recombination of two homologous MHC class III genes of the mouse (C4 and Slp) that accounts for the loss of testosterone dependence of sex-limited protein expression.	C4A C4B	3.80e-05	2	215	2	3794341
Pubmed	WT1 and ACE mRNAs of blood extracellular vesicle as biomarkers of diabetic nephropathy.	ACE WT1	3.80e-05	2	215	2	34246281
Pubmed	Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes.	C4A C4B	3.80e-05	2	215	2	22785613
Coexpression	GSE11924_TFH_VS_TH17_CD4_TCELL_UP	ERBB3 ZFYVE1 ZC3H3 TRIP4 STX4 OSBPL7 HERC1 ITGA10 CHD8 ZNFX1 MCM9	7.61e-07	199	213	11	M3156
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACVRL1 HSPA12B ACE ADCYAP1 KCNC4 SORBS2 ITGA10 ITIH5 HMCN1 EFCC1	3.51e-08	193	214	10	3f8280ef849d95b2fcea5e6824b95a07febc96d0
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2\|TCGA-Kidney / Sample_Type by Project: Shred V9	ZNF423 HEPH GLI2 BMP8A CACNA1C PRRX1 GPR20 ADAMTS2 DCHS1	3.07e-07	186	214	9	1e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRXN3 HERC1 CACNA1C CACNA1D SORBS2 ADAM22 SPTBN4 CHD5 ATP1A3	5.19e-07	198	214	9	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	NRXN3 HERC1 CACNA1C CACNA1D SORBS2 ADAM22 SPTBN4 CHD5 ATP1A3	5.65e-07	200	214	9	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	droplet-Lung-nan-21m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATG2A ITGAL SOWAHC ACE ZBP1 TEDC2 ATP1A3 RAPGEFL1	1.10e-06	160	214	8	0b8151037b28f52a21918856a1e9336e8d5edb90
ToppCell	droplet-Lung-nan-21m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATG2A ITGAL SOWAHC ACE ZBP1 TEDC2 ATP1A3 RAPGEFL1	1.10e-06	160	214	8	4738d0c73d8c3508e5b5beb6c61e0ad551d9b949
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA7 KCNH2 UFSP1 ZNF843 ASPG TEDC2 SHISA8 RAPGEFL1	1.59e-06	168	214	8	de0b00bc405c898d08a06b2e585fb62c0ab9a66e
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADCYAP1 NRXN3 SEMA3B SORBS2 ASPG AOX1 WT1 CHD5	3.53e-06	187	214	8	8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	ZNF423 HSPA12B CILP2 NRXN2 GLI2 GPR20 ZBTB47 THSD7B	3.68e-06	188	214	8	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1 NKD1 HMCN1	3.97e-06	190	214	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GLI2 CACNA1C CACNA1D ADAMTS2 AOX1 NKD1 HMCN1 EFCC1	4.46e-06	193	214	8	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF423 PHLDB1 GLI2 CACNA1C PRRX1 ADAMTS2 AOX1 ELANE	4.81e-06	195	214	8	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1 NKD1 HMCN1	5.00e-06	196	214	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1 NKD1 HMCN1	5.00e-06	196	214	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SOWAHC FAM117A ADAMTSL4 CACNA1C PRRX1 ANKRD46 NKD1 GLIPR1L2	5.19e-06	197	214	8	4edf043e8f586fd375f56485841fe992a18bf853
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACVRL1 HSPA12B ACE KCNC4 SORBS2 ITGA10 ITIH5 HMCN1	5.19e-06	197	214	8	62c0a90869431e582bb7bb329e0b0cc59123d3d1
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACVRL1 HSPA12B ACE KCNC4 SORBS2 ITGA10 ITIH5 HMCN1	5.19e-06	197	214	8	16f0eb047df9d702518f82ee99c6e7dc1350b2fb
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADCYAP1 GLI2 SEMA3B PRRX1 AOX1 WT1 KIF7 AHNAK2	5.38e-06	198	214	8	5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRXN3 CACNA1C CACNA1D SORBS2 ADAM22 SPTBN4 CHD5 ATP1A3	5.38e-06	198	214	8	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADCYAP1 GLI2 SEMA3B PRRX1 AOX1 WT1 KIF7 AHNAK2	5.38e-06	198	214	8	ff6d9455ebfe965cc6f48197172c0ebd3bddde81
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRXN3 CACNA1C CACNA1D SORBS2 ADAM22 SPTBN4 CHD5 ATP1A3	5.38e-06	198	214	8	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADCYAP1 GLI2 SEMA3B PRRX1 AOX1 WT1 KIF7 AHNAK2	5.38e-06	198	214	8	5375a2895cf995f0db4a61861093f01794707901
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1 NKD1 HMCN1	5.38e-06	198	214	8	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRXN3 CACNA1C CACNA1D SORBS2 ADAM22 SPTBN4 CHD5 ATP1A3	5.38e-06	198	214	8	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADCYAP1 GLI2 SEMA3B PRRX1 AOX1 WT1 KIF7 AHNAK2	5.38e-06	198	214	8	35edf6d5bedc2181fbdd56f43e458bc39f4eca16
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1 NKD1 HMCN1	5.38e-06	198	214	8	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ERBB3 ZFYVE1 NRXN3 SEMA3B ZNF598 MINK1 MYO18A MCM9	5.59e-06	199	214	8	a92718a3f1153b8d2196fd343ed5bc0ebc98cad7
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACVRL1 HSPA12B ACE SORBS2 ITGA10 ITIH5 HMCN1 EFCC1	5.59e-06	199	214	8	c5c12c8288fe868322bae9d691b91fee953ceb3e
ToppCell	Tracheal-10x3prime_v2-Stromal-Schwann\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ERBB3 ZFYVE1 NRXN3 SEMA3B ZNF598 MINK1 MYO18A MCM9	5.59e-06	199	214	8	8dc65662c3ca1db2ba0091332f0658abc0afc5de
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1 NKD1 HMCN1	5.80e-06	200	214	8	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1 NKD1 HMCN1	5.80e-06	200	214	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1 NKD1 HMCN1	5.80e-06	200	214	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Adult-Mesenchymal-chondrocyte-D122\|Adult / Lineage, Cell type, age group and donor	GLI2 ACSM5 CACNA1C CACNA1D AOX1 LLGL1 NKD1	7.56e-06	148	214	7	81a1e6fdd942a612bf523c59b8b4974f6ca1fdce
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HOXA1 ACAD11 CACNA1D PLEKHG4 PPL SPTBN4 SHISA8	7.91e-06	149	214	7	68661c8facfb638560bb2e2c20d509941286dacb
ToppCell	droplet-Liver-HEPATOCYTES-1m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGAL ACE ZC3H3 CACNA1D ZBTB47 TTL ATP1A4	9.81e-06	154	214	7	66c93733116e31b65dfb4b0b00de5c39d19cdb84
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	HOXA1 ACAD11 CACNA1D PLEKHG4 MAP10 SPTBN4 SHISA8	9.81e-06	154	214	7	1c62290a2558fd6401b27de5a867d243b143b00a
ToppCell	droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACVRL1 ITGAL ZC3H3 ZBP1 ZBTB47 TTL ATP1A4	1.11e-05	157	214	7	b527e88382c8d21188a0f222b3302523e8816dfc
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IQSEC2 NPHP4 CYP2W1 CACNA1D CPS1 PPL BNIPL	1.16e-05	158	214	7	2ae863ccef201414b82a2ecf7cf1bbb1b0ce4a3c
ToppCell	Globus_pallidus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Gfap_(Gfap)--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	GPR179 HOXA1 GLI2 ACSM5 BMP8A ASPG	1.17e-05	105	214	6	c41264e8b7d306d5d3ffa5b29eb36c7131d1cedf
ToppCell	Globus_pallidus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Gfap_(Gfap)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	GPR179 HOXA1 GLI2 ACSM5 BMP8A ASPG	1.17e-05	105	214	6	ed570cfdd452767dfb4dcae72282fe0fb25a4029
ToppCell	Globus_pallidus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Gfap_(Gfap)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	GPR179 HOXA1 GLI2 ACSM5 BMP8A ASPG	1.17e-05	105	214	6	ed3a431195c42c96c7d9c420e4b9fb00f415012d
ToppCell	facs-Marrow-KLS-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBB3 B3GNT6 ANKRD35 CACNA1C ZBTB47 TLE2 SMPD2	1.66e-05	167	214	7	2812353ff66e76f10bd327ceb0e6b009502a5258
ToppCell	facs-Marrow-KLS-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBB3 B3GNT6 ANKRD35 CACNA1C ZBTB47 TLE2 SMPD2	1.66e-05	167	214	7	d15168f46c1599d9fc68a05a7b822c4b439f2987
ToppCell	Control-CD4+_T_activated\|World / Disease group and Cell class	PANK1 IQCG FLYWCH1 DUSP1 ANKRD46 EBI3 TLE2	2.08e-05	173	214	7	12f8e4276b290bb388a56de4c8d8dd60415b2f63
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	HLCS ZDHHC8 PANK1 IQCG KLC4 EBI3 DHX34	2.41e-05	177	214	7	36b5d29caa9cffbc0284f771a4db71aa72171a89
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CACNA1C CACNA1D ADAMTS2 ADAM22 ITIH5 NKD1	2.69e-05	180	214	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	facs-SCAT\|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE ZBP1 SLC38A10 SEMA3B C4B ADAMTSL4 PRRX1	2.69e-05	180	214	7	6c70b6b7480507fa94625013222ad338ee7dd1d9
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLCS ZDHHC8 PANK1 IQCG KLC4 EBI3 DHX34	2.69e-05	180	214	7	a682a5d55c612709c9ee9fa4289d6f8bef7fe1af
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERBB3 NRXN3 ST3GAL6 BMP8A HSPB2 SORBS2 HMCN1	2.79e-05	181	214	7	a436e7e4c36403257ea90160a58ca0d6d7c0cdfc
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Cd9_(Mural.Rgs5Acta2.Cd9)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CILP2 CACNA1F GPR20 TG ATP1A4	2.87e-05	74	214	5	7c7e45cf219b0be5cf0d0e5ea5daeb32284c8ccd
ToppCell	Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Cd9_(Mural.Rgs5Acta2.Cd9)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CILP2 CACNA1F GPR20 TG ATP1A4	2.87e-05	74	214	5	6183baf43010268f54a6db9332296338f4f74009
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CACNA1C CACNA1D ADAMTS2 LBP NKD1	3.16e-05	125	214	6	b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACVRL1 HSPA12B ST3GAL6 DUSP1 ITIH5 HMCN1 GPCPD1	3.20e-05	185	214	7	7f46ea82a663181957f88e4e83114aef8a78820c
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACVRL1 HSPA12B ST3GAL6 DUSP1 ITIH5 HMCN1 GPCPD1	3.20e-05	185	214	7	956fb0043c0c3e4e5c4d6f58ff95faf6209c380e
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	PHLDB1 GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1	3.20e-05	185	214	7	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	343B-Fibroblasts-Fibroblast-E-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ZNF423 ACAD11 NRXN2 ANKRD35 CACNA1D AOX1 AHNAK2	3.31e-05	186	214	7	1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACVRL1 HSPA12B ST3GAL6 DUSP1 ITIH5 HMCN1 GPCPD1	3.31e-05	186	214	7	ba6ba75218efc26371cea24ddbb0e9b3e3f421ac
ToppCell	343B-Fibroblasts-Fibroblast-E\|343B / Donor, Lineage, Cell class and subclass (all cells)	ZNF423 ACAD11 NRXN2 ANKRD35 CACNA1D AOX1 AHNAK2	3.31e-05	186	214	7	59db239f1864a5d4f1570c93219dbd7ac5b6db35
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACVRL1 HSPA12B ST3GAL6 DUSP1 ITIH5 HMCN1 GPCPD1	3.31e-05	186	214	7	a58c9d1567da0961e0e295a156773d2252ee5a1a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACVRL1 HSPA12B ST3GAL6 DUSP1 ITIH5 HMCN1 GPCPD1	3.31e-05	186	214	7	65e25a9dcef5fc71510aaf170e220deef5b2feb2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACVRL1 HSPA12B ST3GAL6 DUSP1 ITIH5 HMCN1 GPCPD1	3.31e-05	186	214	7	e4f1259725160719e5fd13d76e5a707efed70013
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	C4B ADAMTSL4 PRRX1 PPL ITIH5 HMCN1 AHNAK2	3.55e-05	188	214	7	409a7b69d02e87084ca955e3fe6c77230dee8861
ToppCell	Mesenchymal_cells-Osteoblasts\|World / Lineage and Cell class	SHC2 KCNH2 ALDH1L2 SEMA3B HSPB2 SORBS2 ITGA10	3.55e-05	188	214	7	89f7f5a51be7e046a63e2413f86c521ae4b6718f
ToppCell	Cerebellum-Neuronal-Excitatory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ANKRD63 ADCYAP1 B3GNT6 SLC35F4 TRMT44 BNIPL	3.61e-05	128	214	6	c30ba14320e9b98c9af9e4cd5a8c55380bb9ffa9
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	DISC1 ZBP1 XRRA1 ITIH5 GPBP1L1 GPCPD1 SMPD2	3.67e-05	189	214	7	99b01893da9f9f7c9528afaffad178285211738b
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADCYAP1 NRXN3 SEMA3B SORBS2 ASPG WT1 ITIH5	3.92e-05	191	214	7	4c4eb61e6179d2f8fc524d2f813db9cba84f67a2
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GLI2 CACNA1C CACNA1D ADAMTS2 AOX1 NKD1 HMCN1	3.92e-05	191	214	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NRXN3 GLI2 PRRX1 GPR20 THSD7B ITIH5 NKD1	4.06e-05	192	214	7	24e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	TPO ACVRL1 HSPA12B ACE PHLDB1 SHC2 ITGA10	4.06e-05	192	214	7	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	Entopeduncular-Neuronal\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	NRXN3 FLYWCH1 SPTBN4 CELSR3 CHD5 ATP1A3 JPH3	4.06e-05	192	214	7	4c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GLI2 CACNA1C CACNA1D ADAMTS2 AOX1 NKD1 HMCN1	4.06e-05	192	214	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GLI2 CACNA1C CACNA1D ADAMTS2 NKD1 HMCN1 EFCC1	4.19e-05	193	214	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 NKD1 HMCN1	4.19e-05	193	214	7	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	Control-Stromal-Myofibroblast\|Control / Disease state, Lineage and Cell class	HSPB2 CACNA1C CACNA1D PRRX1 AOX1 NKD1 HMCN1	4.47e-05	195	214	7	ffcf76cd72e43d8cf1058a49c76e0956065038bc
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 NKD1 HMCN1	4.47e-05	195	214	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRXN3 CACNA1C CACNA1D SORBS2 ADAM22 SPTBN4 CHD5	4.62e-05	196	214	7	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	severe-unassigned\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPO DIS3L HNRNPH1 CYP2W1 ENTPD7 ADAM22 ELANE	4.77e-05	197	214	7	70704b149b2820b8601d2495b7cd9cbe91eda262
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 NKD1 HMCN1	4.93e-05	198	214	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1 HMCN1	4.93e-05	198	214	7	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERBB3 NRXN3 ST3GAL6 NRXN2 BMP8A HSPB2 SORBS2	4.93e-05	198	214	7	52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C CACNA1D PRRX1 ADAMTS2 AOX1 NKD1 HMCN1	4.93e-05	198	214	7	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	GLI2 CACNA1C CACNA1D PRRX1 ADAMTS2 NKD1 HMCN1	5.09e-05	199	214	7	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Fibroblasts\|World / lung cells shred on cell class, cell subclass, sample id	HEPH GLI2 HSPB2 CACNA1C PRRX1 AOX1 WT1	5.09e-05	199	214	7	e2b6752fcabd5249a166486ae6796f2c97c1fcaf
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACVRL1 HSPA12B ACE SORBS2 ITGA10 ITIH5 HMCN1	5.09e-05	199	214	7	236b1417ed0875e98c6ec1ec714003bfce438d65
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACVRL1 HSPA12B ACE KCNC4 ITGA10 ITIH5 HMCN1	5.09e-05	199	214	7	1295f34a350bf48987e2fad411aaac3630efd3f1
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACVRL1 HSPA12B ACE KCNC4 SORBS2 ITIH5 HMCN1	5.09e-05	199	214	7	0602e2b2aa56d106da63bd342a38bef437b4d496
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF423 PHLDB1 GLI2 CACNA1C PRRX1 ADAMTS2 AOX1	5.25e-05	200	214	7	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACVRL1 HSPA12B ACE SORBS2 ITGA10 ITIH5 HMCN1	5.25e-05	200	214	7	86ec951234015ced7126b016199e5869a0f22478
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GLI2 CACNA1C PRRX1 ADAMTS2 AOX1 NKD1 HMCN1	5.25e-05	200	214	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C CACNA1D ADAMTS2 ITIH5 NKD1 HMCN1 EFCC1	5.25e-05	200	214	7	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	ZNF423 HSPB2 CACNA1C PRRX1 ADAMTS2 ITIH5 HMCN1	5.25e-05	200	214	7	ca777a7d001848f6d01c613ff2bda7e4f3e20521
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C CACNA1D PRRX1 ADAMTS2 NKD1 HMCN1 EFCC1	5.25e-05	200	214	7	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACVRL1 HSPA12B ACE SORBS2 ITGA10 ITIH5 HMCN1	5.25e-05	200	214	7	061ba851f941c616ddb462512e826c412881c3ce
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN3 ALDH1L2 SEMA3B C4A GPR20 EFCC1	5.96e-05	140	214	6	e442c46979d725ec82f525a001c46d971fcade4d
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	AICDA DIS3L ZSWIM1 CACNA1F AARSD1 EBI3	7.24e-05	145	214	6	b17699f7f98d2361a4d26c26f52db05e7ff69dff
ToppCell	metastatic_Brain-T/NK_cells-Naive_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	ACAD11 KCNC4 HSPB2 CACNA1C ZNF843 ITIH5	7.81e-05	147	214	6	4f7a0c287721befeffabf95b8c5f9ff64149c7c1
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ANKS6 PGLYRP2 KRBA1 PHC1 BNIPL DHX34	8.11e-05	148	214	6	10dcbdb47cac908648d9d652c8095b536db19b8a
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	AICDA DIS3L ZSWIM1 KCNK6 CACNA1F EBI3	8.42e-05	149	214	6	14d2e8cab97108d8fa94e540c1957b73ed32dc73
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	AICDA DIS3L ZSWIM1 KCNK6 CACNA1F EBI3	8.42e-05	149	214	6	54c9c6282f5f5de43dfaf2972fab3e3dcf9838a3
ToppCell	BAL-Mild-Myeloid-TRAM-TRAM2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRIM65 SOWAHC ADAMTSL4 ZBTB47 BNIPL GPCPD1	9.06e-05	151	214	6	28e3f77d2edb30fcf1414762a55ceffaf879d526
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1C CACNA1D CACNA1F	1.41e-06	4	210	3	DOID:0060173 (implicated_via_orthology)
Disease	Autistic Disorder	VWA8 DISC1 ACE HOXA1 NRXN3 NRXN2 C4B CACNA1C CHD8 TBL1XR1	1.94e-05	261	210	10	C0004352
Disease	Neoplasm of uncertain or unknown behavior of bladder	ERBB3 MDM4 TBL1XR1	1.52e-04	15	210	3	C0496930
Disease	Benign neoplasm of bladder	ERBB3 MDM4 TBL1XR1	1.52e-04	15	210	3	C0154017
Disease	Carcinoma in situ of bladder	ERBB3 MDM4 TBL1XR1	1.52e-04	15	210	3	C0154091
Disease	Autoimmune Diseases	TPO AICDA C4B TG	2.26e-04	42	210	4	C0004364
Disease	Carcinoma of bladder	ERBB3 MDM4 TBL1XR1	2.68e-04	18	210	3	C0699885
Disease	Psychomotor Agitation	ADCYAP1 CACNA1C	3.00e-04	4	210	2	C3887612
Disease	amino acid measurement, citrulline measurement	ASPG CPS1	3.00e-04	4	210	2	EFO_0005134, EFO_0009777
Disease	Akathisia	ADCYAP1 CACNA1C	3.00e-04	4	210	2	C0392156
Disease	Acute Promyelocytic Leukemia	ITGAL GLI2 WT1 TBL1XR1	3.22e-04	46	210	4	C0023487
Disease	lysine measurement, amino acid measurement	ASPG CPS1	4.97e-04	5	210	2	EFO_0005002, EFO_0005134
Disease	Immunologic Deficiency Syndromes	MYSM1 C4A CACNA1C	5.67e-04	23	210	3	C0021051
Disease	Anhedonia	DISC1 CACNA1C ATP1A3	6.44e-04	24	210	3	C0178417
Disease	Cardiac Arrhythmia	ACE KCNH2 CACNA1C	7.28e-04	25	210	3	C0003811
Disease	Thyroid Dyshormonogenesis 1	TPO TG	7.42e-04	6	210	2	C1848805
Disease	level of lactase/phlorizin hydrolase in blood serum	DARS1 THSD7B	7.42e-04	6	210	2	OBA_2042177
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP1A3 ATP1A4	1.03e-03	7	210	2	DOID:0060178 (implicated_via_orthology)
Disease	Goiter	TPO TG	1.03e-03	7	210	2	C0018021
Disease	Nephronophthisis, familial juvenile	ANKS6 NPHP4	1.03e-03	7	210	2	C1855681
Disease	amino acid measurement, threonine measurement	ASPG CPS1	1.03e-03	7	210	2	EFO_0005134, EFO_0009775
Disease	Severe congenital neutropenia	HAX1 ELANE	1.03e-03	7	210	2	cv:C1853118
Disease	Depressive disorder	DISC1 ACE ADCYAP1 DCANP1 CACNA1C DUSP1 TG ATP1A3	1.15e-03	289	210	8	C0011581
Disease	postherpetic neuralgia	NRXN3 PLAA	1.37e-03	8	210	2	MONDO_0041052
Disease	NEPHRONOPHTHISIS 2	ANKS6 ZNF423	1.37e-03	8	210	2	C1865872
Disease	mitral valve prolapse (is_implicated_in)	ACE DCHS1	1.76e-03	9	210	2	DOID:988 (is_implicated_in)
Disease	2R,3R-dihydroxybutyrate measurement	AGXT CPS1	1.76e-03	9	210	2	EFO_0800314
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CACNA1C CACNA1D CACNA1F	2.13e-03	36	210	3	DOID:11723 (implicated_via_orthology)
Disease	adult onset asthma, body mass index	ERBB3 TBL1XR1	2.18e-03	10	210	2	EFO_0004340, EFO_1002011
Disease	Holoprosencephaly sequence	GLI2 PRRX1	2.18e-03	10	210	2	cv:C0079541
Disease	Depression, Bipolar	DISC1 CACNA1C CACNA1D PC	2.47e-03	79	210	4	C0005587
Disease	Unipolar Depression	ERBB3 DISC1 MDM4 ACE DCANP1 CACNA1C TG	2.65e-03	259	210	7	C0041696
Disease	glutamine measurement, amino acid measurement	ASPG CPS1	2.66e-03	11	210	2	EFO_0005134, EFO_0009768
Disease	gallbladder neoplasm	ERBB3 KEAP1	2.66e-03	11	210	2	C0016978
Disease	Shortened QT interval	KCNH2 CACNA1C	2.66e-03	11	210	2	C0151879
Disease	Malignant neoplasm of gallbladder	ERBB3 KEAP1	2.66e-03	11	210	2	C0153452
Disease	Graves' disease (is_implicated_in)	C4A C4B TG	2.69e-03	39	210	3	DOID:12361 (is_implicated_in)
Disease	ciliopathy (implicated_via_orthology)	NPHP4 KIF7 PLK4	2.89e-03	40	210	3	DOID:0060340 (implicated_via_orthology)
Disease	Night blindness, congenital stationary, type 1	GPR179 CACNA1F	3.17e-03	12	210	2	C3501847
Disease	pulmonary fibrosis (implicated_via_orthology)	ACE ELANE	3.17e-03	12	210	2	DOID:3770 (implicated_via_orthology)
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	WT1 KIF7	3.17e-03	12	210	2	DOID:3827 (implicated_via_orthology)
Disease	Night Blindness, Congenital Stationary, Type 1A	GPR179 CACNA1F	3.17e-03	12	210	2	C3495587
Disease	nervous system disease (implicated_via_orthology)	ATP1A3 ATP1A4	3.17e-03	12	210	2	DOID:863 (implicated_via_orthology)
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	GPR179 CACNA1F	3.17e-03	12	210	2	C1864877
Disease	Gastrointestinal Diseases	KEAP1 CHD8	3.17e-03	12	210	2	C0017178
Disease	Functional Gastrointestinal Disorders	KEAP1 CHD8	3.17e-03	12	210	2	C0559031
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GPR179 CACNA1F	3.17e-03	12	210	2	C1850362
Disease	Cholera Infantum	KEAP1 CHD8	3.17e-03	12	210	2	C1565321
Disease	X-Linked Csnb	GPR179 CACNA1F	3.17e-03	12	210	2	C3711543
Disease	Congenital neutropenia	HAX1 ELANE	3.17e-03	12	210	2	C0340970
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	GPR179 CACNA1F	3.17e-03	12	210	2	C1848172
Disease	autistic disorder (is_implicated_in)	DISC1 HOXA1 C4B	3.33e-03	42	210	3	DOID:12849 (is_implicated_in)
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	TRIOBP TMEM132E	3.73e-03	13	210	2	C1846647
Disease	Cone-rod synaptic disorder, congenital nonprogressive	GPR179 CACNA1F	3.73e-03	13	210	2	C4041558
Disease	Congenital Hypothyroidism	TPO TG	3.73e-03	13	210	2	C0010308
Disease	Nephronophthisis	ANKS6 NPHP4	3.73e-03	13	210	2	C0687120
Disease	Anxiety States, Neurotic	DISC1 CACNA1C TG	3.80e-03	44	210	3	C0376280
Disease	Anxiety neurosis (finding)	DISC1 CACNA1C TG	3.80e-03	44	210	3	C1279420
Disease	Anxiety Disorders	DISC1 CACNA1C TG	3.80e-03	44	210	3	C0003469
Disease	middle cerebral artery infarction (implicated_via_orthology)	MAG ACE ELANE	4.05e-03	45	210	3	DOID:3525 (implicated_via_orthology)
Disease	Disorder of eye	ZNF423 NPHP4 GPR179 CACNA1F WT1 KIF7	4.23e-03	212	210	6	C0015397
Disease	congenital hypothyroidism (implicated_via_orthology)	TPO TG	4.34e-03	14	210	2	DOID:0050328 (implicated_via_orthology)
Disease	Schizophrenia	MAG ERBB3 DISC1 ARHGEF11 ACE ZDHHC8 ADCYAP1 NRXN3 PLAA NRXN2 KCNH2 HPS4 CACNA1C CACNA1F	4.52e-03	883	210	14	C0036341
Disease	glycerate measurement	THSD7B HMCN1	4.98e-03	15	210	2	EFO_0021029
Disease	calcium measurement	ZMYM2 HEPH CILP2 SEMA5B KCNK6 MYO18A CHD8 CPS1 GPCPD1 ATP1A3 ATP1A4	5.59e-03	628	210	11	EFO_0004838
Disease	response to simvastatin, total cholesterol change measurement, response to fenofibrate	DARS1 PRRX1 TRIOBP	5.76e-03	51	210	3	EFO_0007806, GO_1901557, GO_1903491
Disease	Weight Gain	ACE SORBS2 LBP RFNG	6.16e-03	102	210	4	C0043094
Disease	major depressive disorder (is_marker_for)	DISC1 DUSP1	6.39e-03	17	210	2	DOID:1470 (is_marker_for)
Disease	Antibody Deficiency Syndrome	C4A CACNA1C	6.39e-03	17	210	2	C0003257
Disease	serine measurement, amino acid measurement	ASPG CPS1	6.39e-03	17	210	2	EFO_0005134, EFO_0009774
Disease	Night blindness, congenital stationary	GPR179 CACNA1F	6.39e-03	17	210	2	C0339535

Protein segments in the cluster

Peptide	Gene	Start	Entry
REHAALEPRHLGGRA	ACO2	671	Q99798
PEGHGEVRLHLGFRL	C2orf16	1156	Q68DN1
LDHVRQHRGALGPQL	ERBB3	796	P21860
IVHGCRSLRQNGRDP	ESYT1	991	Q9BSJ8
GLETVPGHQRLERGA	DCANP1	16	Q8TF63
PVRHDGELLRGAARH	CHD8	1926	Q9HCK8
RGPASHLGREETQEI	ADAMTSL4	126	Q6UY14
FADGVPREGLSRQHV	CHD5	1486	Q8TDI0
LDHRGRTLEIPGNSD	C4B	951	P0C0L5
VHDIVNRGGRGLIPV	CPSF3	226	Q9UKF6
VSLRRGANPGFHEAI	ACE	406	P12821
AAPVGRLHRRELQPG	BPIFB4	141	P59827
GGIAGQRLSEHPDIR	ALDH1L2	651	Q3SY69
RGSPLLGDHAVRGAL	FAM117A	176	Q9C073
QLARRLRGEGAGEPT	H3Y2	126	P0DPK5
ATVRGLFGQHGEREP	GPR20	306	Q99678
AEPEGLRRLHRAGVQ	AICDA	121	Q9GZX7
DTRVRGDLGGPQLTH	ADAM22	71	Q9P0K1
LDGENRGIRTRNPIH	ARHGEF11	1171	O15085
RALHSLGVGREPVAD	CYP2W1	131	Q8TAV3
VDAQRRGYHGLGPQR	EAPP	151	Q56P03
RGLPDDHAGPIRVVN	AARSD1	186	Q9BTE6
VREEGRHPQEHRGCG	ACVRL1	56	P37023
RHCLTGGEALNPDVR	ACSM5	341	Q6NUN0
LHRRGLGRAEQPERG	C19orf84	121	I3L1E1
RRGGQRLVQHPDLAS	ANKRD35	246	Q8N283
FDPNIRDSRGRTGLH	ANKRD46	36	Q86W74
AHFGIQLRGGTRLPD	DISC1	116	Q9NRI5
GHGGPEAAVRELRQA	EFCC1	246	Q9HA90
ERSLRELAQPSGGHL	ATG2A	1291	Q2TAZ0
GHGAERILAVPVRTD	ADAMTS2	51	O95450
ELREAHGGRLRFQLP	ABCA7	2046	Q8IZY2
FEISQGRLGPGRIHH	ACAD11	621	Q709F0
AVSAARQERGLHGPL	AOX1	1286	Q06278
GRHRAQGSERPELGR	ANKRD63	241	C9JTQ0
EGPNLPEIRHRGRFA	IQCG	126	Q9H095
ASGGPVLGREHLREL	NKD1	421	Q969G9
QVHLRPDRRGLEPTG	QRICH2	216	Q9H0J4
LDHPIEATERVQGGR	RFNG	176	Q9Y644
HREGISEDPSRLVGQ	KIR3DL2	156	P43630
GALLVARLEGPHEAR	KCNK6	21	Q9Y257
HRAPVVAIAVLDGRG	LLGL1	786	Q15334
LGQRDEPAGHRLSQE	KLC4	6	Q9NSK0
GEGLELHAEGPRRVL	OBSL1	1216	O75147
NHPGIQAELRIREGS	NUP210	906	Q8TEM1
EGRAGHRPQLAELTN	CACNA1F	431	O60840
LTRGGAPERQGEALR	FHIP1B	906	Q8N612
GTAVLRLRAHDPDQG	DCHS1	701	Q96JQ0
VLEARDHGAPGRAAR	DCHS1	2451	Q96JQ0
PQELAEHGVRIVSRG	PCDHGA6	56	Q9Y5G7
DFTGDLRIPHVGRGR	LBP	61	P18428
PRVSEASRGLELGHG	KRBA1	731	A5PL33
ASRGLELGHGRPRVA	KRBA1	736	A5PL33
HQPRIFGGVLESDAR	HAX1	136	O00165
RFPLHNRVGERTGDI	MAP10	161	Q9P2G4
LAGHRQEDGRRGLTE	MAGEC3	351	Q8TD91
GHEGLGEPAVLGRLR	MAG	176	P20916
ILNLEAPRGGRHLDT	HSPB2	141	Q16082
APRGGRHLDTEVNEV	HSPB2	146	Q16082
PLRDLRQEGVRQAHG	ENTPD7	526	Q9NQZ7
HNELRGDVIPRGSNL	GLIPR1L2	61	Q4G1C9
GQPGDILRLVSDHRD	ITIH5	701	Q86UX2
EKRPRDGNIIHGRTG	MDM4	441	O15151
GALERGIQHAPLVIR	GPR179	511	Q6PRD1
RGRHPGVIGLLREAG	ASPG	476	Q86U10
LGPRAGQGVHVVSRA	DYNLT4	176	Q5JR98
EHLPRGEGRFGVSRR	GPBP1L1	31	Q9HC44
LGGLEALRQREHFPN	FLYWCH1	571	Q4VC44
VQRVGGTGRDTPLHV	ASB18	211	Q6ZVZ8
HENPALGRERGGREA	IQSEC2	161	Q5JU85
GVAGNIVRHIPDRGA	GDF1	96	P27539
DRLIGLPEGRARNHN	HERC1	4266	Q15751
IRPAGLHNSARGEVL	HPS4	336	Q9NQG7
HVAGLGPAEERRALV	KCNH2	221	Q12809
APRLRDAGQGTFHRL	KIAA1614	501	Q5VZ46
VRLSPGRLQGHLENE	HLCS	296	P50747
PEAVRQLDRDLHGSG	BNIPL	341	Q7Z465
QPRVHGVALPGLERA	CARMIL3	1151	Q8ND23
RVHIEIGPDGRVTGE	HNRNPH2	316	P55795
GNGRRLHLGIPEAVF	VBP1	16	P61758
LDRGPEGQACRRVVH	MYO18A	241	Q92614
GRELSPEEAHRAGLI	PPL	1666	O60437
GHRQLVRTDCPGDAL	PGLYRP2	521	Q96PD5
ASINLQRGRDHGLPG	TPO	576	P07202
HREGITEDPLRLVGQ	KIR3DL3	156	Q8N743
VRTEGHLRLVGEGPS	NRXN2	1331	Q9P2S2
GRLPDLINDALHRSG	NRXN3	1026	Q9Y4C0
EPGLGRVTLGRDRHF	KIF7	41	Q2M1P5
GNRHRELGVPDSALA	GLI2	1296	P10070
AEPRHGRGRELAQAL	LRRC29	11	Q8WV35
RVHIEIGPDGRVTGE	HNRNPH1	316	P31943
DRFLVGRGVQIGSPH	HOXA1	51	P49639
AALGARGLRVVVPHD	HSPA12B	501	Q96MM6
GEVPAELRRLAHGGQ	NSFL1C	216	Q9UNZ2
VQDLHVGVRPLRAGS	NPHP4	1286	O75161
LSPVGRRQVAGHTRG	SMPD4	791	Q9NXE4
LHNGRELTGREPGIS	HMCN1	1301	Q96RW7
LRFEGHRGQPVGGLR	PCF11	876	O94913
HVLGRAREAQDLGPE	SMPD2	391	O60906
SDPNVRTEGHLRLVG	NRXN2	281	P58401
RTEGHLRLVGEGPSV	NRXN2	286	P58401
RPAGRRDVAHGILNE	ADCYAP1	76	P18509
RPRFLGVAEQLHNEG	CPS1	1371	P31327
RIPLDVGHRGAGNST	GPCPD1	316	Q9NPB8
LHDIGPEIRRAISGD	CACNA1C	1706	Q13936
QHRQRPALGGAGTLE	CSTPP1	181	Q9H6J7
GLEHIVPNAELRGRL	DUSP1	61	P28562
PTRGHRVLGLDALQA	DCDC2C	66	A8MYV0
PNGHFVRVLGRIGDL	DIS3L	406	Q8TF46
RQGAARFHRVGPIEA	EBI3	171	Q14213
PGIFDDVRGSHGRQV	BMP8A	286	Q7Z5Y6
GHIGRAESDPRLDVL	CEP350	466	Q5VT06
AAGGHEPLVRFLLRR	ANKS6	86	Q68DC2
NFVRGLHSEPGLEER	MALSU1	56	Q96EH3
HGGRPEAARLLVVVT	ITGA10	261	O75578
RIRTPHLDALAAGGV	ARSB	66	P15848
GDRVPADLRIISAHG	ATP1A3	186	P13637
ERGGSDPQRQRHLEN	GPR156	516	Q8NFN8
VPRNRIGVGVIDGHI	KEAP1	411	Q14145
LASEIVGGRRARPHA	ELANE	26	P08246
AEGGRREQSPLLHLD	CCDC177	61	Q9NQR7
LRLELQEEPGGRRGH	CELSR3	1851	Q9NYQ7
AEEVIRQHPGAGREL	HELZ2	1461	Q9BYK8
LERAGLAPSGHEGIR	B3GNT6	316	Q6ZMB0
RGSQGLGRHLPAERV	DHX34	116	Q14147
DIRENLVRPGIDHLG	SCAF8	1066	Q9UPN6
RPGITHGVGLVLRVE	SCNN1D	461	P51172
RRRRDLGPHAEGQLA	SLC38A10	1051	Q9HBR0
QAGLRTLHDIGPEIR	CACNA1D	1641	Q01668
NHGLVLSREPLRDGR	NEURL4	71	Q96JN8
LDHRGRTLEIPGNSD	C4A	951	P0C0L4
GGRICLHDIRKPEGQ	FTH1P19	41	P0C7X4
APRHTGLREPRLGQE	DELE1	151	Q14154
DTIGRVGRLHGSVPN	OSBPL7	261	Q9BZF2
ESAGGGEERRVRHPQ	PANK1	81	Q8TE04
GHLPQAGSLERNRVG	MINK1	756	Q8N4C8
RVRGESHLLLVGDPG	MCM9	341	Q9NXL9
RVHIEIGPDGRVTGE	HNRNPF	316	P52597
GFGTEARHQRQPRGS	RPUSD3	36	Q6P087
ELHPDGRHGIVRVDR	TAF7	46	Q15545
RAVDIGERIGARVHP	AGXT	111	P21549
EGHPGRGIDVRRRKI	TRMT44	376	Q8IYL2
RGHGALPDLERAVTE	TMEM132E	416	Q6IEE7
GHPERRLLSVGDGTR	TEDC2	151	Q7L2K0
DVPQGLRGQRAHLFG	PLEKHG4	766	Q58EX7
PAVNGRGERLLLHIG	PIP5K1C	381	O60331
RHLGILGPVIRAEVG	HEPH	451	Q9BQS7
HTGRAGPSVGRNDIR	SELENOO	266	Q9BVL4
NNGPVLGHEEEVGRR	ST3GAL6	146	Q9Y274
GIGARLGLERAHSPR	SHISA8	156	B8ZZ34
LGARHLLERVAPSGG	MRI1	146	Q9BV20
GRAEPGHERRDLPIQ	PPP1R26	626	Q5T8A7
RSQRARGVPHLAEGL	PPP1R26	891	Q5T8A7
RGVPHLAEGLRGTES	PPP1R26	896	Q5T8A7
ALGGEPEQRARARAH	SOWAHC	41	Q53LP3
RGEEILSGAQRIHDP	DARS1	421	P14868
ERVALVVHPGTARLG	STX4	21	Q12846
GLFPGGRHELRRNIA	ITGAL	686	P20701
GRGRVIQDAEERPHS	PLK4	356	O00444
DPSIHLRGRGRANGT	SLC35F4	501	A4IF30
HQDRGGALQDRESPR	SORBS2	826	O94875
LRHCIREGGQDVPSN	TBL1XR1	211	Q9BZK7
GGRTHSPGRAEVERL	TRIOBP	1296	Q9H2D6
PGGVVRAALVVRGQH	ADGRD2	181	Q7Z7M1
EGTPQEGGLRAARLH	AHNAK2	406	Q8IVF2
RRHLLGFSEQEPVQG	ATF6B	436	Q99941
ENGFRPVDLLGIRLH	ATP1A4	881	Q13733
GAHLELRGLRPDQAG	CILP2	341	Q8IUL8
LRDGRADGFIHRIVP	CLEC2A	6	Q6UVW9
RQDSREPDAGRIHAG	TNIP2	341	Q8NFZ5
VEAGRLPAGQRRFAH	URGCP	631	Q8TCY9
HGDLRFTRIQDPQRG	UHRF1BP1L	161	A0JNW5
APQLLGDRRVDAGHT	ZC3H3	256	Q8IXZ2
RRDLIEAAHLGPGGT	ZBTB11	71	O95625
EVLPRLREGAAHLGQ	TRIM11	206	Q96F44
IELRQGEGGVRHLPG	ZCCHC3	301	Q9NUD5
ADPGREGHLEQRILQ	ZBP1	6	Q9H171
RGDPRFAGVRLAVHQ	RP1L1	41	Q8IWN7
EAINRLHEAVPGVRG	SHC2	181	P98077
RPLALQREAHGLRGE	RRP9	356	O43818
QREAHGLRGEPGLEQ	RRP9	361	O43818
GHRAEEPVLRLDPGR	SEMA3B	146	Q13214
HVPRGVGLHGELERL	UFSP1	36	Q6NVU6
GVVTLPGTRDRHGRA	PLEKHG4B	201	Q96PX9
QLPGREHLNEPGTRE	PLAA	336	Q9Y263
EHLNEPGTREGQTRL	PLAA	341	Q9Y263
LPHGGGRHQELVRFR	ZNF840P	31	A6NDX5
HGVFRGIQDVRRVPG	WT1	291	P19544
EVEAHRGPVSGLRRQ	SPTBN4	821	Q9H254
AHGPRLEEVLERAGA	SPTBN4	1566	Q9H254
LEGQSIRAEGGHSRP	SCART1	996	Q4G0T1
PLSVRAGHGERDLGN	PHC1	901	P78364
LADPHGLQFGRRRTE	SEMA5B	806	Q9P283
ILHHLPAGRERGEEG	PHLDB1	1091	Q86UU1
LEGERPHSFRLEQGG	SART1	341	O43290
PATVVLGREDGLQRH	ZBTB47	261	Q9UFB7
GFRVGQALGERLPRE	TRAPPC6A	41	O75865
ATGEFLRNVEGLRHP	ZNFX1	566	Q9P2E3
GLSGHLPGVRQRAIV	ZFYVE1	76	Q9HBF4
GLAHFVNEIRRPNGE	ZMYM2	1121	Q9UBW7
PRHSRRNEGVVGGED	ZNF598	291	Q86UK7
SQHRAAGPLGEARAR	ZNF843	296	Q8N446
IHQRERGGLALEPGR	ZNF212	476	Q9UDV6
RGGDHVALQPLRSEG	ZDHHC8	441	Q9ULC8
EGQDRLAVLLPGRHP	TRIP4	156	Q15650
RHFNGRGPATVDLEL	ZBTB10	151	Q96DT7
LRDHNIRPGEDDGSR	ZNF423	906	Q2M1K9
EGRREPHRGLRVQAD	THSD7B	941	Q9C0I4
LVDGPRVQLEGHLAR	ZSWIM1	96	Q9BR11
LHRGGGQIIPTARRV	EFTUD2	801	Q15029
ARRRGHVTQDAPIPG	EFTUD2	851	Q15029
GHVLERQPALGGRLD	PRRX1	6	P54821
PEHLLNRVLERLAGG	RAPGEFL1	151	Q9UHV5
VDGARGPQILHRVSL	TREML1	106	Q86YW5
GDRQRPEVRLLHAGS	VWA8	36	A3KMH1
HNGEAQRLPGVSGRL	TRIM65	436	Q6PJ69
SDALVGAGIPRHARQ	TLE2	436	Q04725
VQTHIRGFGGDPRRV	TG	2366	P01266
LGERNRLPFGRLGHE	TTL	41	Q8NG68
TGHIRPAVGLRFEVG	UHRF1BP1	1251	Q6BDS2
RDVGVVVHGLPARDL	PLD2	541	O14939
LREGPEGFARAVRNH	PC	546	P11498
LHELGAGRSRAGEPL	TYMP	401	P19971
GRVAREAIQKVHPGG	SNAPC2	71	Q13487
GLGRHAEGRVEPIHA	ZGPAT	351	Q8N5A5
PARNLLRVPEEGQGH	XRRA1	21	Q6P2D8
INHLRARGLQPGEEE	USP13	611	Q92995
ERELALQRLGPHEGG	KCNC4	181	Q03721
DDHRPEDRGFGVQRL	JPH3	641	Q8WXH2
HDGRGIIVDARQLPS	MYSM1	326	Q5VVJ2